Concepedia

Author

Harini Iyer

AstraZeneca (India)

Also Known As

H. Iyer, Harini Iyer, Krishna Iyer, H.

6

Publications

303

Citations

5

H-Index

24

Concepts

All Affiliations

AstraZeneca (India)Uppsala UniversityAstraZeneca (United Kingdom)AstraZeneca (United States)
HI

About

Harini Iyer is an author at AstraZeneca (India) specializing in drug discovery, medicine, and drug resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

303

2

Natural Sciences

3

3

185

3

Biochemistry

3

3

185

4

Chemical Biology

2

2

115

5

Health Sciences

1

1

28

Harini Iyer

×

5

Publications

303

Citations

5

H-Index

YearCitations

Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis

V. Balasubramanian, Suresh Solapure, Harini Iyer,

Antimicrobial Agents and Chemotherapy

2013

90

Design, Synthesis, and X-ray Crystallographic Studies of α-Aryl Substituted Fosmidomycin Analogues as Inhibitors of <i>Mycobacterium tuberculosis</i> 1-Deoxy-<scp>d</scp>-xylulose 5-Phosphate Reductoisomerase

Mounir Andaloussi, L.M. Henriksson, Anna Więckowska,

Journal of Medicinal Chemistry

2011

71

Trisubstituted Imidazoles as <i>Mycobacterium tuberculosis</i> Glutamine Synthetase Inhibitors

Johan Gising, Mikael Nilsson, Luke R. Odell,

Journal of Medicinal Chemistry

2012

70

Structure Guided Lead Generation for <i>M. tuberculosis</i> Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors

Maruti Naik, Anandkumar Raichurkar, Balachandra Bandodkar,

Journal of Medicinal Chemistry

2014

44

Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: An attempt to improve the activity against Mycobacterium tuberculosis

Mounir Andaloussi, Martin Lindh, C. Bjorkelid,

Bioorganic & Medicinal Chemistry Letters

2011

28

Page 1